INSMED Inc SEC filings INSM
INSMED Inc has 1,011 filings in SEC EDGAR's recent list, going back to May 19, 2017. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 1, 2026 | — |
| DEF 14A | Proxy statement | Apr 1, 2026 | May 13, 2026 |
| DEFA14A | Additional proxy material | Apr 4, 2025 | — |
| DEF 14A | Proxy statement | Apr 4, 2025 | May 15, 2025 |
| DEFA14A | Additional proxy material | Apr 1, 2024 | — |
| DEF 14A | Proxy statement | Apr 1, 2024 | May 13, 2024 |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
| DEF 14A | Proxy statement | Mar 31, 2023 | — |
| DEFA14A | Additional proxy material | Apr 1, 2022 | — |
| DEF 14A | Proxy statement | Apr 1, 2022 | May 11, 2022 |
| DEFA14A | Additional proxy material | Apr 1, 2021 | — |
| DEF 14A | Proxy statement | Apr 1, 2021 | May 12, 2021 |
| DEFA14A | Additional proxy material | Mar 31, 2020 | — |
| DEF 14A | Proxy statement | Mar 31, 2020 | May 12, 2020 |
| DEFA14A | Additional proxy material | Apr 4, 2019 | — |
| DEF 14A | Proxy statement | Apr 4, 2019 | May 16, 2019 |
| DEFA14A | Additional proxy material | Apr 5, 2018 | — |
| DEF 14A | Proxy statement | Apr 5, 2018 | May 15, 2018 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INSM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Bridgewater, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1104506
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.